Latest filing published 14 Mar 2024 for Promore Pharma, €39k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anne Dorney: trading record in brief
All filings by Anne Dorney on record concern Promore Pharma. In total, 16 filings cover trades dated from 16 January 2024 to 12 March 2024.
Purchases make up the whole of the open-market record (16 purchases, €174k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The median purchase comes to €4,736. Across 16 purchases, this insider has always bought alone, with no colleague buying within 30 days.
The newest entry dates from 14 March 2024: an open-market purchase of €39k, in Promore Pharma. The median gap between a trade and its publication by Finansinspektionen is 3 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Anne Dorney
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 37,800 shares@ SEK 11.654622.6% of flowAktieISIN SE0021513645FI:csv-22231afd8fa90ab9d2c4Canonical exit: 10 Jun 2024 (T+90)
- 25,000 shares@ SEK 12.12115.6% of flowAktieISIN SE0021513645FI:csv-22bc9f45ab959d7c8fbcCanonical exit: 9 Jun 2024 (T+90)
- 900 shares@ SEK 11.31940.5% of flowAktieISIN SE0021513645FI:csv-8955ce1d7b4be8bddc32Canonical exit: 10 Jun 2024 (T+90)
- 37,000 shares@ SEK 11.539321.9% of flowAktieISIN SE0021513645FI:csv-0be963ab475617a639feCanonical exit: 5 Jun 2024 (T+90)
- 18,000 shares@ SEK 12.212711.2% of flowAktieISIN SE0021513645FI:csv-7eb06c86acf5a6e7839eCanonical exit: 4 Jun 2024 (T+90)
- 17,200 shares@ SEK 11.13269.8% of flowAktieISIN SE0021513645FI:csv-56eab7f23c652f8943a5Canonical exit: 4 Jun 2024 (T+90)
- 3.279 shares@ SEK 9.94820.0% of flowAktieISIN SE0021513645FI:csv-acaa19c16c32a01a9f2eCanonical exit: 29 May 2024 (T+90)
- 14.721 shares@ SEK 10.65150.0% of flowAktieISIN SE0021513645FI:csv-db3439ca33a0667966aeCanonical exit: 30 May 2024 (T+90)
- 208,000 shares@ SEK 0.25732.7% of flowAktieISIN SE0009947740FI:csv-888a85a5ec7ee9b14c02Canonical exit: 21 Apr 2024 (T+90)
- 430,000 shares@ SEK 0.12622.7% of flowAktieISIN SE0009947740FI:csv-0823e6ef4ce4270b9df2Canonical exit: 16 Apr 2024 (T+90)
- 275,000 shares@ SEK 0.11141.6% of flowAktieISIN SE0009947740FI:csv-f554db89169e1cfe0827Canonical exit: 15 Apr 2024 (T+90)
- 110,000 shares@ SEK 0.10250.6% of flowAktieISIN SE0009947740FI:csv-855339d1befe34c52e34Canonical exit: 15 Apr 2024 (T+90)
- 435,000 shares@ SEK 0.12982.9% of flowAktieISIN SE0009947740FI:csv-8e5ad8acb01e531d45d1Canonical exit: 16 Apr 2024 (T+90)
- 348,506 shares@ SEK 0.14722.6% of flowAktieISIN SE0009947740FI:csv-733996bf3210026672a1Canonical exit: 17 Apr 2024 (T+90)
- 348,540 shares@ SEK 0.16522.9% of flowAktieISIN SE0009947740FI:csv-2cf29407998d27974719Canonical exit: 17 Apr 2024 (T+90)
- 255,000 shares@ SEK 0.18872.4% of flowAktieISIN SE0009947740FI:csv-79d2805e9362a27eb283Canonical exit: 18 Apr 2024 (T+90)
16 of 16 declarations